Literature DB >> 30868702

Perceptions about oral isotretinoin treatment.

Burcu Tugrul Ayanoglu1, Hatice G Demirdag1, Basak Yalici Armagan2, Osman Bezirgan1.   

Abstract

There are some studies on the knowledge, beliefs, and perceptions of patients about acne vulgaris, however, there is no sufficient data on patients' beliefs about oral isotretinoin treatment (OIT). The aim of this study was to assess the knowledge, beliefs, and perceptions of the patients with acne vulgaris about the therapy of OIT and its side effects. A total of 214 patients with acne vulgaris in our outpatient clinic were included. Patients who were planned to treat with OIT were asked whether they had information about the treatment and its side effects. It was noted whether the patients accepted treatment after being informed both verbally and written about the OIT details. The study consisted of 133 female and 81 male aged 12-57 years. Most of the patients (78%) stated that they had heard of OIT. The most common source of the information on isotretinoin therapy was friends (57.6%). The dryness was the best-known side effect. While 86.4% of patients (n: 185) accepted OIT, the group (14.4%) stated that "I have knowledge about side effects." And refused to use the treatment. Most of the patients agreed to the treatment after explanation of dermatologist. Patients may be educated and informed via reliable medical sources to prevent bias and improve compliance to the treatment.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  acne; oral isotretinoin treatment; perception

Year:  2019        PMID: 30868702     DOI: 10.1111/dth.12873

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

1.  Systemic isotretinoin therapy in the era of COVID-19.

Authors:  Ayman Abdelmaksoud; Michelangelo Vestita; Heba Saed El-Amawy; Erhan Ayhan; İsa An; Murat Öztürk; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-05-20       Impact factor: 2.851

2.  Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Authors:  Ediléia Bagatin; Caroline Sousa Costa; Marco Alexandre Dias da Rocha; Fabíola Rosa Picosse; Cristhine Souza Leão Kamamoto; Rodrigo Pirmez; Mayra Ianhez; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-10-03       Impact factor: 1.896

3.  Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study.

Authors:  David Moreno-Ramírez; Miguel A Duarte-Ferreras; Teresa Ojeda-Vila; Irene García-Morales; Maria D Conejo-Mir; Almudena Fernández-Orland; Ana I Sánchez-Del-Campo; Noemí Eiris; Ana M Carrizosa; Andrés Ruiz-de-Casas; Jose M de-la-Torre; Juan M Herrerías-Esteban; Lara Ferrándiz
Journal:  J Am Acad Dermatol       Date:  2022-03-07       Impact factor: 15.487

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.